← Back to Search

Behavioural Intervention

Tailored Lighting for Parkinson’s Disease

N/A

Recruiting

Led By Rachel Saunders-Pullman

Research Sponsored by Icahn School of Medicine at Mount Sinai

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up at week 8 for 7 days

Awards & highlights

Study Summary

This trial will assess how lighting can help manage sleep disturbances for people with Parkinson's Disease. 50 participants will wear an Actigraph for 7 days and 30 will receive tailored light intervention.

Who is the study for?

This trial is for individuals with Parkinson's disease who are experiencing sleep problems or cognitive difficulties. There are no specific exclusion criteria, so anyone with these conditions can potentially participate.Check my eligibility

What is being tested?

The study is testing a Tailored Lighting Intervention (TLI) to see if it improves sleep and fatigue in people with Parkinson's. Participants will also wear an Actigraph device for seven days to monitor their sleep patterns.See study design

What are the potential side effects?

Since the intervention involves lighting adjustments, side effects may be minimal but could include discomfort from changes in light exposure or wearing the Actigraph device.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ at week 8 for 7 days

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~at week 8 for 7 days

This trial's timeline: 3 weeks for screening, Varies for treatment, and at week 8 for 7 days for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Sleep duration using Actigraph

Secondary outcome measures

Sleep efficiency using Actigraph

Urine melatonin levels

Trial Design

1Treatment groups

Experimental Treatment

Group I: Tailored Lighting Intervention (TLI)Experimental Treatment2 Interventions

The TLI will be performed for 2 hours each day over an 8-week period During the last week of the lighting, participants will be asked to wear the actigraph and light meter again for 7 days

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

Actigraph

2005

N/A

~1440

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

Icahn School of Medicine at Mount SinaiLead Sponsor

860 Previous Clinical Trials

524,426 Total Patients Enrolled

Rachel Saunders-PullmanPrincipal InvestigatorMount Sinai Beth Israel

1 Previous Clinical Trials

50 Total Patients Enrolled

Media Library

Tailored Lighting Intervention (TLI) (Behavioural Intervention) Clinical Trial Eligibility Overview. Trial Name: NCT05771558 — N/A

Parkinson's Disease Research Study Groups: Tailored Lighting Intervention (TLI)

Parkinson's Disease Clinical Trial 2023: Tailored Lighting Intervention (TLI) Highlights & Side Effects. Trial Name: NCT05771558 — N/A

Tailored Lighting Intervention (TLI) (Behavioural Intervention) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05771558 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is there still an opportunity to take part in this medical research?

"According to the clinicaltrials.gov platform, this trial is currently in need of participants. The research was first published on November 14th 2022 and most recently updated March 14th 2023."

Answered by AI

What is the highest number of participants enrolled in this clinical trial?

"Affirmative. According to information on clinicaltrials.gov, this medical experiment is still recruiting participants and has been posted since November 14th 2022 with the most recent update occurring March 14th 2023. The study requires 50 people from a single site to participate in it."

Answered by AI